PKC 20-28, myristoylated
PKC 20-28, myristoylated (Myristoylated protein kinase C inhibitor 20-28) is a cell-permeable PKC inhibitor that can be used in cancer research[1].
Product Specifications
Product Name Alternative
Myristoylated protein kinase C inhibitor 20-28
UNSPSC
12352209
Target
PKC
Type
Peptides
Related Pathways
Epigenetics; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pkc-20-28-myristoylated.html
Solubility
10 mM in DMSO
Smiles
CCCCCCCCCCCCCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CC(C)C)=O)C)=O)=O)CCCCN)=O)CCCNC(N)=N)=O)C)=O)CC1=CC=CC=C1)=O
Molecular Formula
C60H106N18O11
Molecular Weight
1255.60
References & Citations
[1]Hayabuchi Y, et al. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells. J Mol Cell Cardiol. 2006 Dec;41 (6) :972-9.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040460-500 1x 500 µL
CD44 Standard (156-3C11), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400676-500 1x 500 µL
MUC18 / Mucin 18 / CD146 (OJ79c), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
